EUVIMEDEUVIMED entdecken
Open Access

Biosynthesis, characterization, and antiproliferative activity of gold nanoparticles synthesized using Artemisia chamaemelifolia extract against cisplatin-resistant ovarian cancer cells

Ali Shirafkan, Mohammad Sadegh Hashemzadeh, Mozafar Mohammadi

DARU Journal of Pharmaceutical Sciences · 22.07.2026 · 34 (2)

DOI: 10.1007/s40199-026-00628-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DARU Journal of Pharmaceutical Sciences, online erschienen am 22.07.2026. Verfasst von Ali Shirafkan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nanobiotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Metal Nanoparticles, Gold, Ovarian Neoplasms, Plant Extracts. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ovarian cancer remains a major clinical challenge, largely because many patients eventually develop resistance to cisplatin. In this study, gold nanoparticles (AuNPs) were synthesized using Artemisia chamaemelifolia extract through a green chemistry approach, and their antiproliferative activity was evaluated in cisplatin-resistant A2780cp ovarian cancer cells.

Methods

The aqueous extract of the plant was used as both the reducing and stabilizing agent during nanoparticle formation. The synthesized AuNPs were characterized using UV–Vis spectroscopy, FTIR, FESEM, TEM, and DLS. Cytotoxic effects were assessed using the MTT assay, while apoptosis was evaluated by Annexin V/PI flow cytometry. Changes in the expression of BAX , BCL-2 , TP53 , and CCND1 were assessed by RT-qPCR. HEK293 cells were included as a comparator cell line for cytotoxicity.

Results

UV–Vis spectroscopy showed a surface plasmon resonance peak near 530 nm, confirming nanoparticle formation. FESEM and TEM analyses revealed well-dispersed nanoparticles with predominantly spherical to slightly cubic morphology, an average size of 15.13 nm, and a relatively narrow size distribution. The MTT assay demonstrated dose-dependent cytotoxicity, with an IC₅₀ of 38.83 µg/mL(95% CI: 31.85 to 47.28) in A2780cp cells and no IC₅₀ reached within the tested concentration range for HEK293 cells ( n = 3). Accordingly, the selectivity index (SI) was estimated to be > 5.15, suggesting preferential cytotoxicity toward A2780cp cells. In contrast, cisplatin showed a lower SI of 1.24. Flow cytometry indicated an increase in early apoptotic cells from 16.1 ± 1.2% to 69.2 ± 3.4% ( n = 3), accompanied by a reduction in overall viability. RT-qPCR results were consistent with these findings, showing upregulation of BAX and TP53 and downregulation of BCL-2 and CCND1 .

Conclusion

AuNPs synthesized by this green method exhibited selective cytotoxic and pro-apoptotic activity against cisplatin-resistant ovarian cancer cells. These findings suggest their potential as a biocompatible candidate in strategies aimed at addressing chemoresistance in ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal NanoparticlesGoldOvarian NeoplasmsPlant ExtractsArtemisiaAntineoplastic AgentsHumansFemaleCisplatinDrug Resistance, NeoplasmApoptosisCell ProliferationHEK293 CellsCell Line, TumorGreen Chemistry TechnologyCyclin D1Tumor Suppressor Protein p53Proto-Oncogene Proteins c-bcl-2bcl-2-Associated X ProteinParticle Size

Stichwörter der Autor:innen

ApoptosisCisplatin resistanceGold nanoparticlesGreen synthesisOvarian cancer

Substanzen

GoldCisplatinPlant ExtractsAntineoplastic AgentsCyclin D1Tumor Suppressor Protein p53Proto-Oncogene Proteins c-bcl-2bcl-2-Associated X ProteinCCND1 protein, human

Autor:innen und Institutionen

  • Nanobiotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Nanobiotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. msh.biotechnology@gmail.com.
  • Applied Biotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Shirafkan, A., Hashemzadeh, M. S., & Mohammadi, M. (2026). Biosynthesis, characterization, and antiproliferative activity of gold nanoparticles synthesized using Artemisia chamaemelifolia extract against cisplatin-resistant ovarian cancer cells. DARU Journal of Pharmaceutical Sciences, 34(2). https://doi.org/10.1007/s40199-026-00628-8

Vancouver

Shirafkan A, Hashemzadeh MS, Mohammadi M. Biosynthesis, characterization, and antiproliferative activity of gold nanoparticles synthesized using Artemisia chamaemelifolia extract against cisplatin-resistant ovarian cancer cells. DARU Journal of Pharmaceutical Sciences. 2026;34(2). doi:10.1007/s40199-026-00628-8

BibTeX
@article{Shirafkan2026,
  author = {Shirafkan, Ali and Hashemzadeh, Mohammad Sadegh and Mohammadi, Mozafar},
  title = {Biosynthesis, characterization, and antiproliferative activity of gold nanoparticles synthesized using Artemisia chamaemelifolia extract against cisplatin-resistant ovarian cancer cells},
  journal = {DARU Journal of Pharmaceutical Sciences},
  year = {2026},
  volume = {34},
  number = {2},
  doi = {10.1007/s40199-026-00628-8}
}
Kostenlos starten →